BNIP3L and hepatocellular carcinoma: We validated the relationship between BNIP3/BNIP3L expression and sorafenib resistance in HCC-SR cells by constructing three HCC-SR cell lines (HepG2-SR, HCCLM3-SR, and Huh7-SR).